Carly Kenselaar

Item: Carly Kenselaar
Rating: 3.14
Author: StockAnalysis.com

Stock Analyst at Citigroup

(3.14)

# 1,236

Out of 5,044 analysts

Total ratings

100%

Success rate

84%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Carly Kenselaar

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	KRYS Krystal Biotech	Maintains: Neutral	$155 → $176	$189.65	-7.20%	2	Jul 10, 2025
	TVTX Travere Therapeutics	Maintains: Buy	$35 → $32	$29.81	+7.35%	6	Jun 11, 2025

Krystal Biotech

Jul 10, 2025

Maintains: Neutral

Price Target: $155 → $176

Current: $189.65

Upside: -7.20%

Travere Therapeutics

Jun 11, 2025

Maintains: Buy

Price Target: $35 → $32

Current: $29.81

Upside: +7.35%